Rathbones Group PLC Ptc Therapeutics, Inc. Transaction History
Rathbones Group PLC
- $19 Billion
- Q3 2024
A detailed history of Rathbones Group PLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 23,500 shares of PTCT stock, worth $995,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,500
Previous 23,735
0.99%
Holding current value
$995,930
Previous $725,000
20.14%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
219Shares Held
78.2MCall Options Held
111KPut Options Held
30.6K-
Vanguard Group Inc Valley Forge, PA9.13MShares$387 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$334 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$329 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$313 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$307 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.03B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...